Ceo comes across very well and made some very interesting points.
I think the reward far outweighs the risk on this one, especially for a biotech in phase 3 with
a high chance of success based on phase 2 results.
Company Podcast, page-2
Add TRP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.015(3.30%) |
Mkt cap ! $28.41M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 48.0¢ | 45.5¢ | $38.06K | 81.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10999 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 13119 | 2 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| TRP (ASX) Chart |